In another recent study, the authors performed an RNAi screen on glioma stem cells and determined that the mitochondrial enzyme medium-chain acyl-CoA dehydrogenase (MCAD) was critical for GBM growth (72). The gene discussed is ACADM; the disease is glioblastoma.